Terms: = Astrocytoma AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
1454 results:
1. Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications.
Vageli DP; Doukas PG; Goupou K; Benos AD; Astara K; Zacharouli K; Sotiriou S; Ioannou M
Oncol Res; 2024; 32(8):1239-1256. PubMed ID: 39055895
[TBL] [Abstract] [Full Text] [Related]
2. Stanniocalcin-2 expression in glioblastoma - A novel prognostic biomarker: An observational study.
Aydin AA; Yildirim S
Medicine (Baltimore); 2024 Jul; 103(28):e38913. PubMed ID: 38996177
[TBL] [Abstract] [Full Text] [Related]
3. The CEBPB
Yang Y; Jin X; Xie Y; Ning C; Ai Y; Wei H; Xu X; Ge X; Yi T; Huang Q; Yang X; Jiang T; Wang X; Piao Y; Jin X
Theranostics; 2024; 14(10):4107-4126. PubMed ID: 38994023
[No Abstract] [Full Text] [Related]
4. A novel L-shaped ortho-quinone analog suppresses glioblastoma progression by targeting acceleration of AR degradation and regulating PI3K/akt pathway.
Zhang T; Pan W; Tan X; Yu J; Cheng S; Wei S; Fan K; Wang L; Luo H; Hu X
Biochem Pharmacol; 2024 Aug; 226():116398. PubMed ID: 38944395
[TBL] [Abstract] [Full Text] [Related]
5. Paediatric strategy forum for medicinal product development of PI3-K, mTOR, akt and GSK3β inhibitors in children and adolescents with cancer.
Pearson AD; DuBois SG; Macy ME; de Rojas T; Donoghue M; Weiner S; Knoderer H; Bernardi R; Buenger V; Canaud G; Cantley L; Chung J; Fox E; Friend J; Glade-Bender J; Gorbatchevsky I; Gore L; Gupta A; Hawkins DS; Juric D; Lang LA; Leach D; Liaw D; Lesa G; Ligas F; Lindberg G; Lindberg W; Ludwinski D; Marshall L; Mazar A; McDonough J; Nysom K; Ours C; Pappo A; Parsons DW; Rosenfeld A; Scobie N; Smith M; Taylor D; Weigel B; Weinstein A; Karres D; Vassal G
Eur J Cancer; 2024 Aug; 207():114145. PubMed ID: 38936103
[TBL] [Abstract] [Full Text] [Related]
6. Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma.
Chen J; Liu Y; Lan J; Liu H; Tang Q; Li Z; Qiu X; Hu W; Xie J; Feng Y; Qin L; Zhang X; Liu J; Chen L
CNS Neurosci Ther; 2024 Jun; 30(6):e14802. PubMed ID: 38887185
[TBL] [Abstract] [Full Text] [Related]
7. Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN.
Jacob JR; Palanichamy K; Chakravarti A
Cell Death Dis; 2024 Jun; 15(6):414. PubMed ID: 38871731
[TBL] [Abstract] [Full Text] [Related]
8. Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of rac-1.
He L; Ioannidis A; Hoffman CJ; Arambula E; Joshi P; Whitelegge J; Liau LM; Kornblum HI; Pajonk F
Cancer Res Commun; 2024 Jun; 4(6):1566-1580. PubMed ID: 38837899
[TBL] [Abstract] [Full Text] [Related]
9. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
Chen Y; Yu J; Ge S; Jia R; Song X; Wang Y; Fan X
Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):8. PubMed ID: 38837168
[TBL] [Abstract] [Full Text] [Related]
10. Targeting the interaction of pleiotrophin and VEGFA
Choleva E; Menounou L; Ntenekou D; Kastana P; Tzoupis Η; Katraki-Pavlou S; Drakopoulou M; Spyropoulos D; Andrikopoulou A; Kanellopoulou V; Enake MK; Beis D; Papadimitriou E
Eur J Pharmacol; 2024 Aug; 977():176692. PubMed ID: 38821164
[TBL] [Abstract] [Full Text] [Related]
11. Bufotalin enhances apoptosis and TMZ chemosensitivity of glioblastoma cells by promoting mitochondrial dysfunction via akt signaling pathway.
Zhu Z; Liang S; Hong Y; Qi Y; Sun Q; Zhu X; Wei Y; Xu Y; Chen Q
Aging (Albany NY); 2024 May; 16(10):9264-9279. PubMed ID: 38809514
[TBL] [Abstract] [Full Text] [Related]
12. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
[No Abstract] [Full Text] [Related]
13. Approaches to selective and potent inhibition of glioblastoma by vanadyl complexes: Inducing mitotic catastrophe and methuosis.
Xu S; Liu H; Li X; Zhao J; Wang J; Crans DC; Yang X
J Inorg Biochem; 2024 Aug; 257():112610. PubMed ID: 38761580
[TBL] [Abstract] [Full Text] [Related]
14. METTL8 links mt-tRNA m
Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST
Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809
[TBL] [Abstract] [Full Text] [Related]
15. LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B.
Dong N; Qi W; Wu L; Li J; Zhang X; Wu H; Zhang W; Jiang J; Zhang S; Fu W; Liu Q; Qi G; Wang L; Lu Y; Luo J; Kong Y; Liu Y; Zhao RC; Wang J
J Exp Clin Cancer Res; 2024 May; 43(1):139. PubMed ID: 38725030
[TBL] [Abstract] [Full Text] [Related]
16. Targeted inhibition of branched-chain amino acid metabolism drives apoptosis of glioblastoma by facilitating ubiquitin degradation of Mfn2 and oxidative stress.
Lu Z; Sun GF; He KY; Zhang Z; Han XH; Qu XH; Wan DF; Yao D; Tou FF; Han XJ; Wang T
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167220. PubMed ID: 38718847
[TBL] [Abstract] [Full Text] [Related]
17. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.
Stouffer M; Wandling E; Dickson L; Lin S; Duan H; Powe E; Jean-Louis D; Tiwari AK; Amos S
Cancer Rep (Hoboken); 2024 May; 7(5):e2051. PubMed ID: 38702989
[TBL] [Abstract] [Full Text] [Related]
18. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis.
Guo M; Zhang J; Han J; Hu Y; Ni H; Yuan J; Sun Y; Liu M; Gao L; Liao W; Ma C; Liu Y; Li S; Li N
J Transl Med; 2024 May; 22(1):419. PubMed ID: 38702818
[TBL] [Abstract] [Full Text] [Related]
19. Small-molecule Molephantin induces apoptosis and mitophagy flux blockage through ROS production in glioblastoma.
Ling Z; Pan J; Zhang Z; Chen G; Geng J; Lin Q; Zhang T; Cao S; Chen C; Lin J; Yuan H; Ding W; Xiao F; Xu X; Li F; Wang G; Zhang Y; Li J
Cancer Lett; 2024 Jun; 592():216927. PubMed ID: 38697460
[TBL] [Abstract] [Full Text] [Related]
20. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
[Next]
